Effect of Maridebart Cafraglutide on How Oral Contraceptives Are Absorbed and Processed in the Body in Postmenopausal Female Participants Living With Overweight or Obesity
Clinical trial NCT07523711 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07523711
- Sponsor
- Amgen
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-09
- Primary completion
- 2026-11-18
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.